This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
In a news item concerning the recent retirement of Dr. Simon Flexner, published in The Journal, June 22, page 2274, the statement was made that Dr. Flexner "was the first to use the meningococcus antitoxin." The term "antimeningitis serum" should have been used, as the statement referred to Dr. Flexner's early work on that serum and not to the recent antitoxin developed by Ferry and used by Hoyne (The Journal, March 23, p. 980).
Antimeningococcic Antitoxin. JAMA. 1935;105(12):975. doi:10.1001/jama.1935.02760380051019
Customize your JAMA Network experience by selecting one or more topics from the list below.